Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New program aims to help young people recover from first psychotic episodes

NCT ID NCT03919760

Knowledge-focused Sponsor: Centre for Addiction and Mental Health Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested a program called NAVIGATE, which provides coordinated care for youth and young adults (ages 14-35) who have had a first episode of psychosis. The goal was to see if NAVIGATE helps improve recovery, reduce hospital stays, and lower healthcare costs compared to standard care. Researchers worked with 100 participants across multiple early psychosis programs in Ontario, using video conferencing and data analysis to track outcomes.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

100 people

The number who actually took part.

Started

Jan 2020

Finished

Dec 2024

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

14 to 35 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Early psychosis intervention (EPI) programs from specific geographic regions of Ontario will be included. Investigators will recruit consecutive referrals to the EPI programs participating in the study. All of the EPI sites follow people experiencing a first episode psychosis. Individual inclusion criteria: * Age range of 14-35 years; * any DSM-diagnosis that can manifest as early psychosis (schizophrenia, schizoaffective disorder, schizophreniform disorder, bipolar I disorder, major depressive disorder with psychotic features, substance induced psychotic disorder, or unspecified psychotic disorder); Exclusion Criteria: * Absence of psychosis * Inability to provide informed consent to participate in the research study

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Affective disorders, psychotic are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Affective Disorders, Psychotic bipolar I disorder childhood-onset schizophrenia major depressive disorder Psychological Well-Being psychotic disorder Psychotic Disorders schizoaffective disorder schizophrenia Schizophrenia Spectrum and Other Psychotic Disorders Schizophrenia, Childhood schizophreniform disorder substance-induced psychosis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Affective disorders, psychotic Bipolar I disorder First episode psychosis Psychosis Psychotic disorder due to unspecified substance Schizoaffective disorder Schizophrenia Schizophrenia spectrum and other psychotic disorders Schizophrenia, childhood Schizophreniform disorders

Contacts and locations

Locations

  • CMHA Waterloo Wellington

    Waterloo, Ontario, N2J 4M1, Canada

  • Durham Amaze- Lakeridge Health

    Oshawa, Ontario, L1G 2B9, Canada

  • First Place Clinic and Regional Resource Centre

    Thunder Bay, Ontario, P7A4K9, Canada

  • Health Sciences North

    Greater Sudbury, Ontario, P3E 5J1, Canada

  • Niagara Region Public Health

    Thorold, Ontario, L2V 4Y6, Canada

  • North Bay Regional Health Centre

    North Bay, Ontario, P1B 0A4, Canada

More trials for these conditions

Other studies related to the condition(s) this trial covers.